ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published online before print October 1, 2008
Eur Respir J 2008, doi:10.1183/09031936.00092008
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
33/2/332    most recent
09031936.00092008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Condliffe, R.
Right arrow Articles by Pepke-Zaba, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Condliffe, R.
Right arrow Articles by Pepke-Zaba, J.


ORIGINAL ARTICLE

Prognostic and Aetiological Factors in Chronic Thromboembolic Pulmonary Hypertension

R. Condliffe 1, D.G. Kiely 2, J.S.R. Gibbs 3, P.A. Corris 4, A.J. Peacock 5, D.P. Jenkins 6, K. Goldsmith 6, J.G. Coghlan 7, J. Pepke-Zaba 6*

1 Pulmonary Vascular Disease Unit, Papworth Hospital, Cambridge, United Kingdom; and Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, United Kingdom
2 Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, United Kingdom
3 Dept of Cardiology, Hammersmith Hospital, London, United Kingdom
4 Northern Vascular Unit, Freeman Hospital, Newcastle-upon-Tyne, United Kingdom; and Institute of Cellular Medicine, Newcastle University, Newcastle-upon-Tyne, United Kingdom
5 Scottish Pulmonary Vascular Unit, Western Infirmary, Glasgow, United Kingdom
6 Pulmonary Vascular Disease Unit, Papworth Hospital, Cambridge, United Kingdom
7 Dept of Cardiology, Royal Free Hospital, London, United Kingdom

* To whom correspondence should be addressed. E-mail: joanna.pepkezaba{at}papworth.nhs.uk.


   Abstract

Several prognostic variables have been previously identified in patients with chronic thromboembolic pulmonary hypertension (CTEPH). Specific medical conditions have also been associated with the development and prognosis of CTEPH. Using a national registry we have assessed the prognostic value of a larger number of variables. We have also attempted to validate the clinical importance of previously identified aetiological factors.

Baseline information for all 469 CTEPH patients diagnosed in the UK pulmonary hypertension service between January 2001 and June 2006 was collected from hospital records.

Although univariate analysis confirmed the prognostic importance of pulmonary resistance, in multivariate analysis gas transfer and exercise capacity predicted pulmonary endarterectomy perioperative mortality. Cardiac index and exercise capacity independently predicted outcome in patients with non-operable disease. Previous splenectomy was noted in 6.7% of patients, being significantly more common in patients with non-operable than operable disease (13.7% v 3.6%, p<0.001). We did not find that medical risk factors predicted mortality.

In this large national cohort, predictors of outcome in patients with both operable and non-operable CTEPH have been identified. These may be useful in planning treatment. The aetiological importance of previously identified medical risk factors has been confirmed, although we were unable to validate their prognostic strength.

Keywords:  Endarterectomy, prognosis, pulmonary hypertension, thromboembolism




This article has been cited by other articles:


Home page
ERRHome page
O. Sanchez, B. Planquette, and G. Meyer
Update on acute pulmonary embolism
Eur. Respir. Rev., September 1, 2009; 18(113): 137 - 147.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. M. Keogh, E. Mayer, R. L. Benza, P. Corris, P. G. Dartevelle, A. E. Frost, N. H. Kim, I. M. Lang, J. Pepke-Zaba, and J. Sandoval
Interventional and surgical modalities of treatment in pulmonary hypertension.
J. Am. Coll. Cardiol., June 30, 2009; 54(1 Suppl): S67 - S77.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. M. Hoeper, J. A. Barbera, R. N. Channick, P. M. Hassoun, I. M. Lang, A. Manes, F. J. Martinez, R. Naeije, H. Olschewski, J. Pepke-Zaba, et al.
Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension.
J. Am. Coll. Cardiol., June 30, 2009; 54(1 Suppl): S85 - S96.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. Humbert
Update in Pulmonary Hypertension 2008
Am. J. Respir. Crit. Care Med., April 15, 2009; 179(8): 650 - 656.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by the European Respiratory Society.